KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Long-Term Investments (2016 - 2025)

Evolent Health has reported Long-Term Investments over the past 12 years, most recently at $2.7 million for Q4 2025.

  • Quarterly results put Long-Term Investments at $2.7 million for Q4 2025, down 81.96% from a year ago — trailing twelve months through Dec 2025 was $2.7 million (down 81.96% YoY), and the annual figure for FY2025 was $2.7 million, down 81.96%.
  • Long-Term Investments for Q4 2025 was $2.7 million at Evolent Health, up from $2.7 million in the prior quarter.
  • Over the last five years, Long-Term Investments for EVH hit a ceiling of $17.6 million in Q2 2023 and a floor of $2.7 million in Q3 2025.
  • Median Long-Term Investments over the past 5 years was $12.6 million (2021), compared with a mean of $10.7 million.
  • Biggest five-year swings in Long-Term Investments: surged 359.2% in 2023 and later tumbled 81.96% in 2025.
  • Evolent Health's Long-Term Investments stood at $13.0 million in 2021, then fell by 3.94% to $12.5 million in 2022, then skyrocketed by 35.28% to $16.9 million in 2023, then dropped by 11.06% to $15.0 million in 2024, then tumbled by 81.96% to $2.7 million in 2025.
  • The last three reported values for Long-Term Investments were $2.7 million (Q4 2025), $2.7 million (Q3 2025), and $9.0 million (Q2 2025) per Business Quant data.